Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...
While it’s unclear how much funding will ultimately be available, the change could broaden the number of departments able to ...
The Nissan GT-R has outlived product cycles, trend shifts, and regulatory pressure because it delivers something enthusiasts ...
The online gambling capital has reshaped motorsport economics, replacing traditional automotive brands in funding ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
The research highlights that AI adoption does not occur in a vacuum. Students do not evaluate technology purely on technical ...
Health outcomes for children with intellectual and developmental disabilities (IDD) are consistently worse than for children without IDDs. Recent estimates suggest that between 2-3% of US children ...
This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...
Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...
People.ai, the leading AI data platform for sales teams, has been recognized as a Visionary in the 2025 Gartner® Magic Quadrant™ for Revenue Action Orchestration. The Magic Quadrant evaluates vendors ...